Clover Health plans trade in 16,942 Class A shares

Clover Health Investments Corp. (CLOV) reports a planned transaction involving Class A Common Stock held through Morgan Stanley Smith Barney LLC.

Rhea-AI Filing Summary

Clover Health Investments Corp. (CLOV) reports a planned transaction involving Class A Common Stock held through Morgan Stanley Smith Barney LLC. The filing lists 16,942 shares linked to restricted stock units granted on August 16, 2026 as compensation from the issuer.

It also notes a prior sale of 4,630 Class A shares on July 15, 2026 for a reported amount of $21,622.10, executed as a 10b5-1 Plan Sale by Joseph Clay Thornton.

Key Figures

Reported share quantity linked to RSUs: 16,942 shares Reported dollar amount with Morgan Stanley entry: $72,342.34 RSU grant date: 2026-08-16 +3 more

6 metrics

Reported share quantity linked to RSUs 16,942 shares Quantity associated with restricted stock units granted on August 16, 2026

Reported dollar amount with Morgan Stanley entry $72,342.34 Dollar figure listed with 16,942 Class A shares and August 17, 2026 date

RSU grant date 2026-08-16 Date shown for restricted stock units from issuer as compensation

Recent 10b5-1 sale shares 4,630 shares Shares of Class A Common Stock sold on July 15, 2026

Recent 10b5-1 sale value $21,622.10 Reported amount for 4,630 shares sold on July 15, 2026

Date associated with Morgan Stanley entry 2026-08-17 Date listed with 16,942 Class A shares in securities information

Key Terms

Restricted Stock Units, 10b5-1 Plan Sale, Class A Common Stock

3 terms

Restricted Stock Units financial

"Class A Common Stock | 08/16/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Plan Sale regulatory

"10b5-1 Plan Sale Joseph Clay Thornton 1209 Orange Street"

Class A Common Stock financial

"Class A Common Stock | Morgan Stanley Smith Barney LLC"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What CLOV securities are referenced in this Form 144 filing?

The filing references Class A Common Stock of Clover Health Investments Corp. (CLOV). It ties these shares to restricted stock units granted on August 16, 2026 as compensation and to a prior sale executed on July 15, 2026.

How many CLOV shares are associated with the reported restricted stock units?

The restricted stock units correspond to 16,942 shares of CLOV Class A Common Stock. These RSUs are shown as granted on August 16, 2026 from the issuer in connection with compensation, according to the transaction detail provided.

What prior CLOV share sale is disclosed in this Form 144 for Joseph Clay Thornton?

The filing discloses a 10b5-1 Plan Sale of CLOV Class A Common Stock by Joseph Clay Thornton. On July 15, 2026, 4,630 shares were sold for a reported value of $21,622.10, as listed in the recent sales section.

Which broker is involved with the CLOV Class A Common Stock in this filing?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This firm is associated with the CLOV Class A Common Stock position described in the securities information section.

On what date is the CLOV Class A Common Stock transaction associated with Morgan Stanley noted?

The securities information section lists a date of August 17, 2026 in connection with the CLOV Class A Common Stock held through Morgan Stanley Smith Barney LLC. This date is presented alongside the reported share quantity and dollar amount figures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:27 PM Accepted by SEC EDGAR 08/17/2026 - 04:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002128794
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clover Health Investments, Corp.
SEC File Number	001-39252
Address of Issuer	1209 Orange Street Wilmington DELAWARE 19801
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	Joseph Clay Thornton
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 8th Floor New York NY 10004	16942	72342.34	435441337	08/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	08/16/2026	Restricted Stock Units	Issuer			16942	08/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Plan Sale Joseph Clay Thornton 1209 Orange Street Wilmington DE 19801	Class A Common Stock	07/15/2026	4630	21622.1

144: Remarks and Signature

Remarks	The proposed sales reported represent shares to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. The purpose of the proposed sales is to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the reporting person.
Date of Notice	08/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Peter J. Rivas as attorney-in-fact for Joseph Clay Thornton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)